3 hours GeneDx (NASDAQ:WGS) Price Target Increased to $54.00 by Analysts at The Goldman Sachs GroupMarketBeat
The Goldman Sachs Group boosted their price target on GeneDx from $32.00 to $54.00 and gave the company a “neutral” rating in a research note on Wednesday.
Goldman Sachs (GS) · Nasdaq 100 · Science
X